Developed in collaboration with Yuwell Medical, Voxi 5 presents a viable option for patients seeking reliable stationary oxygen therapy, delivering 1-5 L/min of quiet 1, pure 2, continuous flow oxygen ...

Inogen (INGN +5.2%) rose pre-market following its Q4 results on Feb. 24 post market. Q4 total revenue rose 3.3% Y/Y to $76.4M, missing analysts' estimates of $76.60M. The increase was mainly driven by ...

Inogen INGN shares ended the last trading session 5% higher at $13.35. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to ...

Inogen (INGN) shares soared 5.1% in the last trading session to close at $27.82. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the ...

It has been about a month since the last earnings report for Inogen (INGN). Shares have lost about 5.9% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading ...

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release ...